|Post IPO Valuation|
|Venture Round, 7/2013 ||$1.09M|
|Venture Round, 9/2013 ||$2.8M|
|Venture Round, 11/2013 ||$2.63M|
Through our leading network of more than 2,100 dialysis facilities in North America and our vascular access centers, laboratory, pharmacy and affiliated hospitals and nephrology practices, Fresenius Medical Care provides renal services to hundreds of thousands of people throughout the United States, Mexico and Canada. We are also the continent’s top producer of dialysis equipment, dialyzers and related disposable products and a major supplier of renal pharmaceuticals.
Fresenius Medical Care North America is a division of Fresenius Medical Care (NYSE: FMS), the world’s largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.1 million individuals worldwide.